OPC-415

· Otsuka Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OPC-415, covering 2025-05-25 to 2025-05-25. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of OPC-415 in Patients With Relapsed and/or Refractory Multiple Myeloma [Phase 1, Phase 2]

See pricing